|0.26|| +0.005 / +1.96%|
Aeolus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development of medical countermeasures against biological, chemical, and radiological weapons in the United States. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. The company primarily develops AEOL 10150, a phase I clinical trial lead product for various indications, such as a medical countermeasure against the effects of acute radiation syndrome in the lungs and gastro-intestinal tract, and as a medical countermeasure against the effects of chlorine gas. Aeolus Pharmaceuticals was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.
|David C. Cavalier||Chairman, Chief Financial Officer & Secretary|
|John L. McManus||President & Chief Executive Officer|
|Christopher Stanley||Vice President-Operations|
|Brian J. Day||Chief Scientific Officer|
|Cindy Croissant||Director-Clinical Operations|